These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6602328)

  • 21. A comparison of the effects of zomepirac and aspirin on fecal blood loss.
    Johnson PC
    J Clin Pharmacol; 1980; 20(5-6 Pt 2):401-5. PubMed ID: 6967492
    [No Abstract]   [Full Text] [Related]  

  • 22. Myofascial headache. Exacerbation of symptoms due to diflunisal and ranitidine therapy. A case report.
    Lapeer GL
    J Can Dent Assoc; 1987 Aug; 53(8):635-6. PubMed ID: 3308026
    [No Abstract]   [Full Text] [Related]  

  • 23. [Erythema multiforme and Stevens-Johnson syndrome following diflunisal therapy].
    Dubois A; Malbos S; Chevreau P; Hansel S; Janbon C
    Nouv Presse Med; 1982 Feb; 11(8):606-7. PubMed ID: 7070999
    [No Abstract]   [Full Text] [Related]  

  • 24. Three cases of diflunisal hypersensitivity.
    Cook DJ; Achong MR; Murphy FR
    CMAJ; 1988 Jun; 138(11):1029-30. PubMed ID: 2967101
    [No Abstract]   [Full Text] [Related]  

  • 25. Diflunisal (Dolobid).
    Med Lett Drugs Ther; 1982 Aug; 24(616):76-8. PubMed ID: 6981050
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of gastro-intestinal blood loss after antrafenine, aspirin and placebo in healthy volunteers (author's transl)].
    Bown RL; Martin BK; Gordon A; Seymour D; Rovei V; Gomeni C; Narbonne G; Coquelin JP
    Therapie; 1980; 35(6):685-91. PubMed ID: 6972101
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastrointestinal microbleeding in normal subjects receiving acetylsalicylic acid, placebo, and R-803, a new antiinflammatory agent, in a design balanced for residual effects.
    Arsenault A; LeBel E; Lussier A
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):473-80. PubMed ID: 1086311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diflunisal 500-750 mg versus aspirin 2600-3900 mg in the treatment of rheumatoid arthritis.
    Turner RA; Whipple JP; Shackleford RW
    Pharmacotherapy; 1984; 4(3):151-7. PubMed ID: 6377249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective adverse reactions to diflunisal.
    Arias J; Fernández-Rivas M; Moral A; García MA; Senent CJ
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):160-2. PubMed ID: 7697476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the animal and clinical pharmacology of diflunisal.
    Davies RO
    Pharmacotherapy; 1983; 3(2 Pt 2):9S-22S. PubMed ID: 6344042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of diflunisal and tilidine in tumor pain].
    Brückle W; Lydtin H
    Fortschr Med; 1984 Mar; 102(9):241-3. PubMed ID: 6706281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diflunisal in rheumatoid arthritis.
    Fishel B; Weiss S; Yaron M
    Inflammation; 1981 Sep; 5(3):253-61. PubMed ID: 7028626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of broperamole, a new antiinflammatory agent, on gastrointestinal microbleeding in the dog.
    Leeling J; Muni I; Johnson N
    Arzneimittelforschung; 1980; 30(7):1113-4. PubMed ID: 6968218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects].
    Bretagne JF; Feuillu A; Gosselin M; Gastard J
    Gastroenterol Clin Biol; 1984 Jan; 8(1):28-32. PubMed ID: 6698337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diflunisal versus aspirin: a comparative study of their effect of faecal blood loss, in the presence and absence of alcohol.
    De Schepper PJ; Tjandramaga TB; Verhaest L; Daurio C; Steelman SL
    Curr Med Res Opin; 1978; 5(7):520-4. PubMed ID: 699626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin, paracetamol, diflunisal, and gastrointestinal blood-loss.
    Tringham VM; Cochrane P
    Lancet; 1979 Jun; 1(8131):1409. PubMed ID: 87870
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of salicylic acid with adenosine and adenosine triphosphate. Potential mechanism of intensifying acetylsalicylic acid-induced GI blood loss.
    Asker AF; Whitworth CW
    Pharmazie; 1976; 31(10):728-30. PubMed ID: 14340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for the 12-hour evaluation of analgesic efficacy in outpatients with postoperative oral surgery pain. Three studies of diflunisal.
    Beaver WT; Forbes JA; Shackleford RW
    Pharmacotherapy; 1983; 3(2 Pt 2):23S-37S. PubMed ID: 6856487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of misoprostol in controlling indomethacin induced fecal blood loss in arthritic patients.
    Jallad NS; Cattan A; Weidler DJ
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):376-81. PubMed ID: 8225682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.